Invesco Ltd. Abb Vie Inc. Transaction History

Invesco Ltd.

$453 Billion
Q1 2024

A detailed history of Invesco Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Invesco Ltd. holds 5,318,206 shares of ABBV stock, worth $912 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

5,318,206

Previous 5,268,315 0.95%

Holding current value

$912 Million

Previous $816 Million 18.62%

% of portfolio

0.21%

Previous 0.2%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $7.97 Million - $9.09 Million	49,891 Added 0.95%	5,318,206 $968 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $146 Million - $165 Million	-1,063,733 Reduced 16.8%	5,268,315 $816 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $39.1 Million - $45.2 Million	-292,483 Reduced 4.42%	6,332,048 $944 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $195 Million - $243 Million	-1,470,727 Reduced 18.17%	6,624,531 $893 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $131 Million - $150 Million	-902,953 Reduced 10.03%	8,095,258 $1.29 Billion

Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $72.4 Million - $86.9 Million	523,667 Added 6.18%	8,998,211 $1.46 Billion
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $88.5 Million - $102 Million	659,564 Added 8.44%	8,474,544 $1.14 Billion
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $227 Million - $288 Million	1,648,278 Added 26.73%	7,814,980 $1.2 Billion
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $38.9 Million - $48.3 Million	294,978 Added 5.02%	6,166,702 $1 Billion
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $79.4 Million - $101 Million	739,492 Added 14.41%	5,871,724 $795 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $31.3 Million - $35.6 Million	294,395 Added 6.09%	5,132,232 $554 Million
Q2 2021 Aug 17, 2021	SELL	$105.21 - $117.21 $13.7 Million - $15.3 Million	-130,514 Reduced 2.63%	4,837,837 $545 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $83.6 Million - $92 Million	817,182 Added 19.69%	4,968,351 $538 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $13.3 Million - $18 Million	165,439 Added 4.15%	4,151,169 $445 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $45.7 Million - $53.7 Million	532,295 Added 15.41%	3,985,730 $349 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $88 Million - $118 Million	1,200,007 Added 53.25%	3,453,435 $339 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $104 Million - $157 Million	-1,609,739 Reduced 41.67%	2,253,428 $172 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $28 Million - $35 Million	-387,517 Reduced 9.12%	3,863,167 $342 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $7.16 Million - $8.61 Million	-113,658 Reduced 2.6%	4,250,684 $322 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $93.9 Million - $120 Million	1,429,584 Added 48.71%	4,364,342 $317 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $26.2 Million - $30.9 Million	340,108 Added 13.11%	2,934,758 $237 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $202 Million - $249 Million	2,594,650 New	2,594,650 $239 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account